OSR Health, Inc. Chairman and Chief Executive Officer Kuk Hyoun Hwang filed a Form 4 on November 19, 2026, disclosing the acquisition of 1,173,697 shares of common stock on October 29, 2026, in settlement of accrued unpaid salary under the company's 2025 Omnibus Incentive Plan.

Key Highlights

  • Transaction date: October 29, 2026, with 1,173,697 shares of OSRH common stock acquired directly by the reporting person.
  • Price per share: $0.2272, described in the filing as equal to 115% of the volume-weighted average price of the common stock for the 15 trading days ended October 28, 2026.
  • Purpose: Shares were issued under the OSR Health, Inc. 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, according to the filing.
  • Board approval and exemption: The award was approved by the issuer's Board of Directors and Compensation Committee and is described as exempt under Rule 16b-3(d).
  • Lock-up: The acquired shares are subject to a six-month contractual lock-up from the grant date, per the filing.
  • Indirect holdings: Following the transaction, Hwang is also reported to beneficially own 8,612,636 shares indirectly through BCM Europe AG, 3,123,970 shares through Bellevue Capital Management LLC, and 1,332,500 shares through Bellevue Global Life Sciences Investors LLC.

Hwang's October 2026 Salary-Settlement Share Award at OSR Health

According to the Form 4 filed with the SEC on November 19, 2026, Kuk Hyoun Hwang, who serves as Chairman and Chief Executive Officer of OSR Health, Inc. (OTC:OSRH), acquired 1,173,697 shares of OSRH common stock on October 29, 2026. The filing identifies the transaction code as "A" (acquired) and states the price per share as $0.2272.

The filing explains that the shares represent common stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan "in settlement of accrued unpaid salary, at a price per share of $0.2272, equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026." The award was approved by the issuer's Board of Directors and Compensation Committee and is described as "exempt under Rule 16b-3(d)." The shares are stated to be "subject to a six-month contractual lock-up from the grant date."

Following the reported transaction, Hwang directly owns 1,173,697 shares. In addition, the filing reports indirect beneficial ownership of 8,612,636 shares held by BCM Europe AG, 3,123,970 shares held by Bellevue Capital Management LLC, and 1,332,500 shares held by Bellevue Global Life Sciences Investors LLC. The filing states that Hwang "may be deemed to beneficially own the shares held by" those entities "by virtue of his control of such entities," but notes he "disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."

What Was Disclosed

The filing disclosed a single acquisition of 1,173,697 shares of OSR Health common stock by Chairman and CEO Kuk Hyoun Hwang on October 29, 2026, at $0.2272 per share, issued under the company's 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, subject to a six-month lock-up.